Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Bright Momchilovtsi Yogurt
BRIGHT MINDS BIOSCIENCES INC.
Constipation
1 trial -
Buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Human Immunodeficiency Virus
1 trial -
Buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Buspirone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Use Disorders
1 trial -
Caffeine
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Cannabis (30% THC Concentrate)
BRIGHT MINDS BIOSCIENCES INC.
THC
1 trial -
Cigarette
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
1 trial -
Clopidogrel
BRIGHT MINDS BIOSCIENCES INC.
Metabolism of Clopidogrel
1 trial -
Cognitive behavioral therapy for anxiety plus benzodiazepine taper
BRIGHT MINDS BIOSCIENCES INC.
Anxiety Disorders
1 trial -
Depot Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Erythromycin 4% topical gel formulation:
BRIGHT MINDS BIOSCIENCES INC.
Inflammation; Skin
1 trial -
Escitalopram
BRIGHT MINDS BIOSCIENCES INC.
Depressive Disorder, Major
1 trial -
Fibre mixture
BRIGHT MINDS BIOSCIENCES INC.
Health Status
1 trial -
Fluoxetine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Galantamine
BRIGHT MINDS BIOSCIENCES INC.
Addiction
1 trial -
Goal2Quit + NRT Sampling
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Guselkumab
BRIGHT MINDS BIOSCIENCES INC.
Psoriasis Vulgaris
1 trial -
HCV+PWID
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
HLA-B*5801 test
BRIGHT MINDS BIOSCIENCES INC.
Stevens-Johnson Syndrome
1 trial -
Hydroxychloroquine Sulfate 200 MG [Plaquenil]
BRIGHT MINDS BIOSCIENCES INC.
Coronavirus Infection
1 trial -
IMIQUIMOD cream 50mg/g
BRIGHT MINDS BIOSCIENCES INC.
Cutaneous Lupus Erythematosus
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources